Reprometabolic Syndrome Mediates Subfertility in Obesity
common.study.values.description
“Reprometabolic Syndrome Mediates Subfertility in Obesity”
Obesity plays an adverse role at every stage of conception and pregnancy and mounting evidence implicates relative hypogonadotropic hypogonadism, and reduced menstrual cycle hormone secretion as likely contributors to the subfertility phenotype and possible contributors to complications of pregnancy and the developmental origin of adult diseases such as diabetes and cardiovascular disease. This study will be the first comprehensive investigation to tie together the patterns of hyperinsulinemia, hyperlipidemia and inflammation, characteristic of obesity and obesity-caused relative hypogonadotropic hypogonadotropism and its potential adverse reproductive outcomes. The investigators findings will be used to inform a subsequent clinical intervention to optimize reproductive outcomes for obese women and their offspring.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Drug - Insulin
Drug - Intralipid
Drug - Dextrose
Drug - Heparin
Drug - GnRH
Procedure - Hyperinsulinemic Euglycemic Clamp
participant.views.study.view.additional
participant.views.study.view.scientific-title
Reprometabolic Syndrome Mediates Subfertility in Obesity
common.study.values.clinical-trial-id
NCT02653092
participant.views.study.view.id
QdJWye